CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Adjusted EPS | ₹24.43 | ₹14.80 | ₹13.89 | ₹13.89 |
What is the latest Earnings Per Share (EPS) of CORONA REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹24.43 |
| Mar2025 | ₹14.80 |
| Mar2024 | ₹13.89 |
| Mar2023 | ₹13.89 |
How is Earnings Per Share (EPS) of CORONA REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹24.43 | 65.07 | |
| Mar2025 | ₹14.80 | 6.55 | |
| Mar2024 | ₹13.89 | 0.00 | |
| Mar2023 | ₹13.89 | - | |
Compare Earnings Per Share (EPS) of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,096.2 Cr | 1.3% | 5.6% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 1.3% |
5.6% |
|
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses